Life Sciences

This is the fifth edition of Egon Zehnder International’s annual biotech survey, based on interviews with a broad selection of senior executives, non-executives and investors in the European sector of the industry. 

This year’s survey focuses on what companies can do to help ensure that they have an effective board. Of course this is hardly a topic of exclusive relevance to biotechnology businesses.

In just ten years – about two average CEO tenures – the search for CEO talent will become even more challenging as most baby boomers will have retired. Strategic boards will understand this today and insist that their companies take action to create a talent bench now by bringing in executives from other industries and providing them with development plans that can potentially lead to the top job.